Berlin - Delayed Quote EUR
CytomX Therapeutics Inc (6C1.BE)
1.8460
+0.0620
+(3.48%)
As of 4:03:05 PM GMT+2. Market Open.
Loading Chart for 6C1.BE
- Previous Close
1.7840 - Open
1.7810 - Bid 1.6280 x --
- Ask 1.9210 x --
- Day's Range
1.7810 - 1.8740 - 52 Week Range
0.3656 - 2.2280 - Volume
0 - Avg. Volume
34 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 6C1.BE
View MorePerformance Overview: 6C1.BE
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
6C1.BE
78.53%
S&P 500 (^GSPC)
0.81%
1-Year Return
6C1.BE
2.61%
S&P 500 (^GSPC)
11.94%
3-Year Return
6C1.BE
12.29%
S&P 500 (^GSPC)
47.94%
5-Year Return
6C1.BE
51.98%
S&P 500 (^GSPC)
107.05%
Compare To: 6C1.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6C1.BE
View MoreValuation Measures
As of 5/15/2025
Market Cap
143.85M
Enterprise Value
79.69M
Trailing P/E
4.16
Forward P/E
2.66
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16
Price/Book (mrq)
6.42
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
2.37
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--